Growth Metrics

Calidi Biotherapeutics (CLDI) Equity Ratio (2021 - 2025)

Calidi Biotherapeutics' quarterly Equity Ratio came in at 0.42 in Q4 2025, up 205.84% year-on-year from 0.14 in Q4 2024, and down 17.28% quarter-over-quarter from 0.51 in Q3 2025.

Calidi Biotherapeutics has reported Equity Ratio for 5 years, with the latest figure at 0.42 in Q4 2025.

  • For the quarter ending Q4 2025, Equity Ratio rose 205.84% year-over-year to 0.42; the trailing twelve-month figure through Dec 2025 stood at 0.42 (up 205.84% YoY), and the FY2025 full-year result was 0.42, up 205.84% from the prior year.
  • Equity Ratio for Q4 2025 stood at 0.42, down from 0.51 in the prior quarter.
  • The five-year high for Equity Ratio was 0.51 in Q3 2025, with the low at 19.42 in Q4 2022.
  • Average Equity Ratio over 5 years is 1.65, with a median of 0.17 recorded in 2022.
  • Year-over-year, Equity Ratio plunged 14139.9% in 2022 and surged 205.84% in 2025.
  • Tracing CLDI's Equity Ratio over 5 years: stood at 0.14 in 2021, then sank by 14139.9% to 19.42 in 2022, then soared by 95.77% to 0.82 in 2023, then jumped by 116.88% to 0.14 in 2024, then surged by 205.84% to 0.42 in 2025.
  • The last three Equity Ratio figures came in at 0.42 (Q4 2025), 0.51 (Q3 2025), and 0.22 (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Equity Ratio (Qtr)
1 Quantum Biopharma 1,638,563.89 Bn 1,638,563.89 Bn - 0.04
2 Alterity Therapeutics 767,934.24 Bn 767,934.20 Bn - -
3 Legend Biotech 2,937.00 Bn 2,936.10 Bn 242.10 Mn -
4 Nanobiotix 2,282.79 Bn 2,282.72 Bn - -
5 Akari Therapeutics 2,169.69 Bn 2,169.69 Bn - 0.42
6 Vertex Pharmaceuticals 110.41 Bn 103.16 Bn 2.59 Bn 0.73
7 Regeneron Pharmaceuticals 66.44 Bn 57.69 Bn 3.31 Bn 0.77
8 Evaxion A 65.44 Bn 65.42 Bn - -
9 Alnylam Pharmaceuticals 39.53 Bn 36.52 Bn 959.66 Mn 0.21
10 Calidi Biotherapeutics - - - 0.42

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 0.42
Sep 30, 2025 0.51
Jun 30, 2025 0.22
Mar 31, 2025 0.48
Dec 31, 2024 0.14
Sep 30, 2024 -1.47
Jun 30, 2024 -1.83
Mar 31, 2024 -1.97
Dec 31, 2023 -0.82
Sep 30, 2023 -0.06
Jun 30, 2023 -1.45
Mar 31, 2023 -1.28
Dec 31, 2022 -19.42
Sep 30, 2022 -1.04
Jun 30, 2022 -0.17
Mar 31, 2022 -0.16
Dec 31, 2021 -0.14